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Mice with Genetic Deletion of Group VIA Phospholipase A2 Exhibit
Impaired Macrophage Function and Increased Parasite Load in
Trypanosoma cruzi-Induced Myocarditis
Janhavi Sharma,a Jennifer R. Blase,b Daniel F. Hoft,b John O. Marentette,a John Turk,c Jane McHowata
Department of Pathologya and Division of Infectious Diseases, Department of Internal Medicine,b Saint Louis University School of Medicine, St. Louis, Missouri, USA;
Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USAc
Trypanosoma cruzi infection, which is the etiological agent of Chagas disease, is associated with intense inflammation during the
acute and chronic phases. The pathological progression of Chagas disease is influenced by the infiltration and transmigration of
inflammatory cells across the endothelium to infected tissues, which are carefully regulated processes involving several molecu-
lar mediators, including adhesionmolecules and platelet-activating factor (PAF). We have shown that PAF production is depen-
dent upon calcium-independent group VIA phospholipase A2 (iPLA2) following infection of human coronary artery endothe-
lial cells (HCAECs) with T. cruzi, suggesting that the absence of iPLA2may decrease the recruitment of inflammatory cells to
the heart to manage parasite accumulation. Cardiac endothelial cells isolated from iPLA2-knockout (iPLA2-KO) mice infected
with T. cruzi demonstrated decreased PAF production compared to that by cells isolated from wild-type (WT) mice but demon-
strated increases in adhesionmolecule expression similar to those seen inWTmice. Myocardial inflammation in iPLA2-KO
mice infected with T. cruziwas similar in severity to that inWTmice, but the iPLA2-KOmouse myocardium contained more
parasite pseudocysts. Upon activation, macrophages from iPLA2-KOmice produced significantly less nitric oxide (NO) and
caused less T. cruzi inhibition than macrophages from wild-type mice. Thus, the absence of iPLA2 activity does not influence
myocardial inflammation, but iPLA2 is essential for T. cruzi clearance.
Trypanosoma cruzi is a protozoan parasite that results in signif-icant cardiac pathology and is the etiological agent of Chagas
disease. It is estimated that over 10 million people worldwide are
currently infected with T. cruzi, and of these, about 300,000 reside
in the United States (1). Chagas disease is endemic to South and
Central America, where people risk acquiring the parasite from
the triatomine insect vector. Chagas disease progresses from an
acute stage, which may or may not be symptomatic, to a chronic
stage, in which 20 to 30% of infected individuals exhibit cardiac
involvement thatmay lead to heart failure, arrhythmias, and death
(2). The long asymptomatic period separating the two stages of the
disease is known as the indeterminate phase and may last for sev-
eral decades.
During the acute stage of T. cruzi infection, the parasites infect
the myocardium, leading to an intense inflammatory response.
Several proinflammatory cytokines and signaling pathways are
activated to facilitate the transmigration of inflammatory cells in
an attempt to control parasite invasion. Activation of the endo-
thelium and upregulation of endothelial cell adhesion molecules,
such as intercellular adhesion molecule 1 (ICAM-1) and vascular
cell adhesion molecule 1 (VCAM-1), following T. cruzi infection
are critical for these processes (3). Our group has previously dem-
onstrated increased expression of platelet-activating factor (PAF),
in addition to the upregulation of adhesion molecules, in human
coronary artery endothelial cells (HCAECs) acutely infected with
T. cruzi (4). The role of PAF in the recruitment, transmigration,
and activation of inflammatory cells is well established (5–8).
PAF is an acetylated alkyl ether glycerophospholipid that can
elicit biological effects at concentrations as low as 1012 M (9).
Mice treated with a PAF receptor antagonist demonstrate earlier
mortality and increased parasitemia, suggesting that PAF is nec-
essary for resistance to Chagas disease (10). Further, PAF-defi-
cientmice have increased parasitemia, increased tissue parasitism,
a more intense inflammatory response in the heart, and increased
mortality following infection with T. cruzi (11). Thus, PAF pro-
duction may be a critical host defense response to T. cruzi infec-
tion that serves to retard the progression of Chagas disease. Earlier
studies have suggested that PAF can induce nitric oxide (NO)
production in macrophages infected with T. cruzi (10).
Although studies have described the role of PAF in T. cruzi
infection, much less information concerning the mechanism un-
derlying PAF accumulation is available. We recently demon-
strated that PAF production requires calcium-independent group
VIA phospholipase A2 (iPLA2) and is greatly blunted in
iPLA2-knockout (iPLA2-KO) mice (4). Although we have fo-
cused on iPLA2-mediated PAF production in the cardiovascular
system, the enzyme is also involved in modulating arachidonic
acid release from vascular cells and vasomotor tone (12).We have
shown that the absence of endothelial cell iPLA2 activity is asso-
ciated with a decrease in prostacyclin release. The predominant
iPLA2 isoform in the myocardium is the calcium-independent
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group VIB PLA2 (iPLA2), which is responsible for the produc-
tion of arachidonic acid-derived eicosanoids. Although few stud-
ies to date have addressed the role of phospholipase A2 (PLA2) in
myocarditis, several inflammatory metabolites produced follow-
ing PLA2-catalyzed hydrolysis of membrane phospholipids have
been implicated in Chagas disease (10, 11, 13). Finally, previous
studies have suggested that iPLA2may be required for inducible
nitric oxide synthase (iNOS) upregulation, increased NADP oxi-
dase 4 (Nox4) expression, and chemotaxis in macrophages (14,
15). Here, we compared wild-type (WT) and iPLA2-KOmice to
determine whether iPLA2 deficiency influences cardiac inflam-
mation and parasite accumulation following T. cruzi infection.
MATERIALS AND METHODS
Parasitology. Tissue culture trypomastigotes (TCTs) from the Brazil
strain of T. cruzi were propagated in NIH 3T3 mouse embryonic fibro-
blasts grown in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 2% neonatal calf serum. NIH 3T3 cells were infected with T.
cruziwhen 60% confluence was reached. Infected cells ruptured following
parasite multiplication, releasing an abundant number of parasites. The
supernatant containing the parasites was collected, and parasite numbers
were determined using a Neubauer hemocytometer.
Mice and infections. Animal protocols were in strict accordance with
the National Institutes of Health guidelines for the humane treatment of
animals and were reviewed and approved by the Animal Care and Use
Committee of Saint Louis University. C57BL/6 WT or iPLA2-KO mice
were used for in vitro and in vivo studies. Mice were infected subcutane-
ously with 5,000 Brazil strain blood-form trypomastigotes (BFTs) and
sacrificed at different time points postinfection. The hearts were collected
in paraformaldehyde fixative or frozen in liquid nitrogen before process-
ing for histological analysis. The hearts were trimmed, processed, and
embedded in paraffin. Five-micrometer tissue sections were cut, and sec-
tions were stained with hematoxylin and eosin (H&E). The investigators
were blind to the identity of the samples, as numerical identifiers specific
to each individual mouse were used, and the samples were evaluated mi-
croscopically using a 4-point system as described previously (16, 17). The
parasite pseudocysts in 20 separate bright-field regions of the ventricle
were counted.
Murine endothelial cell isolation. Endothelial cells were isolated
from mouse heart by collagenase digestion. The diced heart muscle was
incubated in 2 mg/ml collagenase for 1 h at 37°C, and the digested tissue
was passed through a cell strainer. Cells were incubated with murine im-
munoglobulins to block Fc receptors and then incubatedwith anti-mouse
platelet endothelial cell adhesionmolecule 1 (PECAM-1) coupled tomag-
netic beads. The cells obtained were cultured until they reached conflu-
ence and sorted again using ICAM-2 antibodies coupled with magnetic
beads. The eluted cells were washed, resuspended in cell culture medium,
and plated. Nonadherent cells were removed on the next day, and cells
were grown to confluence and passaged at a 1-to-3 dilution.
PAF assay. Murine cardiac endothelial cells grown in 12-well culture
dishes were washed twice with Hanks’ balanced salt solution containing
135 mMNaCl, 0.8 mMMgSO4, 10 mMHEPES (pH 7.4), 1.2 mM CaCl2,
5.4 mM KCl, 0.4 mM KH2PO4, 0.3 mM Na2HPO4, and 6.6 mM glucose
and incubated with 50 Ci [3H]acetic acid for 20 min. After the selected
time interval for incubation with the appropriate agents, lipids were ex-
tracted from the cells by the method of Bligh and Dyer. The chloroform
layer was concentrated by evaporation under N2, applied to a silica gel 60
thin-layer chromatography plate, and developed in chloroform-metha-
nol-acetic acid-water (50:25:8:4, vol/vol). The region corresponding to
PAF was scraped, and the radioactivity was quantified using liquid scin-
tillation spectrometry. The loss of PAF during extraction and chromatog-
raphy was corrected for by adding a known amount of [14C]PAF as an
internal standard. [14C]PAF was synthesized by acetylating the sn-2 posi-
tionof lyso-PAFwith [14C]acetic anhydride using 0.33Mdimethylamino-
pyridine as a catalyst. The synthesized [14C]PAF was purified by high-
pressure liquid chromatography.
Endothelial cell surface expression of adhesion molecules. Murine
cardiac endothelial cells were grown to confluence in 16-mm culture
dishes and were incubated with T. cruzi (multiplicity of infection [MOI],
0.2) for up to 96 h. At the end of the incubation, the cells were fixed with
1%paraformaldehyde and incubated overnight at 4°C. The cells were then
washed three times with phosphate-buffered saline (PBS) and then
blocked with Tris-buffered saline–Tween 20 supplemented with 0.8%
(wt/vol) bovine serum albumin and 0.5% (wt/vol) fish gelatin for 1 h at
24°C. Appropriate primary antibody (1:50; Santa Cruz Biotechnology,
Santa Cruz, CA) was used before treatment with horseradish peroxidase-
conjugated rabbit anti-goat immunoglobulin secondary antibody (1:
5,000; Santa Cruz Biotechnology, Santa Cruz, CA). Subsequently, each
well was incubated in the dark with a 3,3=,5,5=-tetramethylbenzidine liq-
uid substrate system, and color development was measured at 450 nm.
Isolation of murine BMDMs. Bone marrow-derived macrophages
(BMDMs) were isolated from the femurs of WT and iPLA2-KO mice.
Briefly, mice were sacrificed, and the femurs were removed and cleansed
of tissue. The marrows were flushed from the femurs using DMEM, dis-
rupted by passage through a 23-gauge needle, and collected by centrifu-
gation. The pellets were resuspended in ACK lysis buffer (0.15 M NH4Cl,
10mMKHCO3, 0.10mMEDTA), and incubated for 10min on ice to lyse
the red blood cells. The cells were centrifuged and resuspended in bone
marrow conditionedmedium supplementedwith 20% fetal bovine serum
(FBS) and 1% penicillin-streptomycin devoid of macrophage colony-
stimulating factor (M-CSF). Following 2 to 3 h of incubation at 37°C with
5% CO2, nonadherent cells were decanted and resuspended in fully sup-
plemented bone marrow conditioned medium (with M-CSF). Cells were
plated in 100-mmculture dishes for 5 to 7 days, followingwhich theywere
used for experiments.
Nitrite release from murine macrophages. The nitrite released into
the culture supernatants obtained from RAW 264.7 cells or murine bone
marrow-derivedmacrophages wasmeasured. Cells were grown to conflu-
ence and infected with T. cruzi (MOI, 0.2) with or without interferon
gamma (IFN-; 100 units/ml) for 24 h. The nitrite concentration was
measured by mixing 50 l of the culture supernatant with the Griess
reagent system. The absorbance at 550 nm of each sample was measured,
and the concentration of nitrite was determined with reference to a nitrite
standard curve with nitrite concentrations ranging from 0 to 100 M.
T. cruzi inhibition assay. BMDMswere plated in 8-well tissue culture
slide chambers (Nunc Lab-Tek; Thermo Scientific, Waltham,MA) at 1
105 cells/well in DMEM with 10% FBS. After overnight culture at 37°C,
nonadherent cells were washed away andmacrophages were infected with
T. cruzi culture-derivedmetacyclic trypomastigotes (CMTs) at anMOI of
5 (5 105 parasites/well) for 3 h. The generation of CMTs was described
previously (18). Extracellular parasites were then washed away, and fresh
medium or medium containing purified IFN- (100 U/ml; Sigma Chem-
ical Co., St. Louis, MO) was added. Two days later, the slide chambers
were removed from the slides, and the slides were washed, dried, fixed,
and stained with a modifiedWright Giemsa stain (Diff-Quik; IMEB, Inc.,
San Marcos, CA). The number of infected macrophages was determined
microscopically. Percent inhibitionwas calculated by use of the following:
{1 [(number of infected cells per 200 cells treatedwith IFN-)/(number
of infected cells per 200 cells treated with medium alone)]} 100.
Statistical analysis. Comparison of the values for statistically signifi-
cant differences was performed by Student’s t test or one-way analysis of
variance with post hoc analysis, performed using Dunnett’s test. All results
are expressed as themean standard error of themean (SEM). Statistical
significance was considered to be a P value of0.05.
RESULTS
PAF production and adhesion molecule expression in cardiac
endothelial cells. Our previous in vitro studies indicated that
iPLA2 is critical for recruiting inflammatory cells to the endothe-
Sharma et al.
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lium via the production of PAF (4, 6). Thus, we measured PAF
production and the expression of adhesion molecules in cardiac
endothelial cells isolated fromWT and iPLA2-KO mice (Fig. 1).
Cardiac endothelial cells isolated from WT mice demonstrated a
significant increase in cell surface expression of intercellular ad-
hesion molecule 1 (ICAM-1) and vascular cell adhesion molecule
1 (VCAM-1) when incubated with T. cruzi for up to 48 h (Fig. 1).
The increase in adhesion molecules was accompanied by a signif-
icant increase in PAF accumulation inT. cruzi-infectedWT endo-
thelial cells (Fig. 1). When endothelial cells isolated from
iPLA2-KO mice were incubated with T. cruzi, a significant in-
crease in cell surface expression of ICAM-1 and VCAM-1 similar
to that seen with cells isolated from WT mice was observed (Fig.
1). However, PAF production inT. cruzi-infected endothelial cells
isolated from iPLA2-KO mouse heart was significantly reduced
compared to that in endothelial cells isolated from WT mouse
heart (Fig. 1). Thus, the absence of iPLA2 is associated with im-
paired PAF production but does not affect the cell surface expres-
sion of adhesion molecules in response to T. cruzi infection.
Studies in iPLA2-KO mice. WT and iPLA2-KO mice were
infected with the Brazil strain of T. cruzi (5,000 parasites), and
cardiac inflammation was measured by histopathological evalua-
tion, as described in Materials and Methods, and assigned a
FIG 1 Expression of ICAM-1 and VCAM-1 and PAF production in endothe-
lial cells isolated from the hearts of WT and iPLA2-KOmice infected with T.
cruzi (MOI, 0.2) for up to 48 h. Values are normalized to those observed in the
absence of infection. The values shown are means SEMs for 4 separate cell
cultures. *,P 0.05 compared to untreated controls; **,P 0.01 compared to
untreated controls.
FIG 2 (A) Myocardial inflammation score for WT and iPLA2-KO mice following T. cruzi infection for up to 12 weeks. (B) Number of parasites in the
myocardium per field for WT and iPLA2-KO mice following T. cruzi infection for 4 weeks. **, P 0.01 compared to WT. The results in panels A and B are
means SEMs for at least 6 separate samples. (C)Hematoxylin-and-eosin-stained sections of hearts fromWTand iPLA2-KOmice following 4weeks ofT. cruzi
infection. Arrows, parasite pseudocysts in the myocardium.
iPLA2 in T. cruzi Myocarditis
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numerical value on the basis of the size and severity of the
inflammatory foci. Cardiac inflammation was observed in WT
and iPLA2-KO mice at 2, 4, and 8 weeks postinfection but
resolved by week 12 (Fig. 2A). No difference in the inflamma-
tion score between WT and iPLA2-KO mice was observed at
any time point at which the score was determined following
infection with T. cruzi (Fig. 2A), but the number of parasite
pseudocysts was increased in the hearts of iPLA2-KOmice com-
pared to the hearts of WTmice at 4 weeks postinfection (Fig. 2B).
These data suggest that iPLA2 deficiency does not significantly
affect the transmigration of inflammatory cells following T. cruzi
infection but that parasite clearance is impaired in iPLA2-defi-
cient mice and that iPLA2 could play a protective role in acute
infection.
Nitrite production by RAW 264.7 macrophages. Macro-
phages play a critical role in clearingT. cruzi via the release of nitric
oxide (NO). The myocardium of iPLA2-KO mice had an in-
flammation score comparable to that of the myocardium of
WT mice, but the myocardium of iPLA2-KO mice had an
increased number of pseudocysts, which suggests that macro-
phages from iPLA2-KOmice may be deficient in their parasite
clearance ability.
To examine the role of iPLA2 in macrophage responses to T.
cruzi infection, RAW 264.7 cells were infected (MOI, 0.2; 48 h) in
the absence or presence of the (R)- or (S)-enantiomer of the iPLA2
inhibitor bromoenol lactone (BEL; 0.5M). NO release wasmea-
sured by colorimetric determination of the amount of nitrite, a
stable breakdown product of NO, produced. Infection with T.
cruzi resulted in a significant increase in NO release (Fig. 3), and
this was significantly augmented by coincubation with interferon
gamma (IFN-), a known activator of the macrophage iNOS
pathway (Fig. 3). Pretreatment of RAW 264.7 cells with the
calcium-independent group VIB PLA2 (iPLA2) inhibitor (R)-
BEL did not significantly affect NO release following T. cruzi in-
fection with or without IFN- (Fig. 3), but pretreatment with the
iPLA2 inhibitor (S)-BEL significantly reduced NO release in re-
sponse to T. cruzi infection in the presence or absence of IFN-
(Fig. 3).
Nitrite production and parasite intracellular inhibition by
mouse BMDMs. Bone marrow-derived macrophages (BMDMs)
were isolated from WT and iPLA2-KO mice, and their NO pro-
duction was determined bymeasurement of the amount of nitrite
after incubation with T. cruzi with or without IFN-. As with
RAW264.7 cells (Fig. 4),T. cruzi infection stimulatedNOproduc-
tion by WTmouse BMDMs, and this was amplified by coincuba-
tion with IFN- (Fig. 4A). Pretreatment with (S)-BEL but not
(R)-BEL significantly inhibited the WT mouse BMDM NO pro-
duction stimulated by T. cruzi infection with or without IFN-
(Fig. 4A). BMDMs isolated from iPLA2-KOmice released negli-
gible amounts of NO compared to the amount released by WT
mouse macrophages (Fig. 4B). These data indicate that iPLA2 is
important for NO production by macrophages, which is critical
for parasite clearance in the acute stage of T. cruzi infection. Fi-
nally, inhibition of intracellular replication of T. cruzi was signif-
icantly greater in BMDMs derived from WT mice than BMDMs
derived from iPLA2-KO mice (Fig. 4C). Thus, we conclude that
iPLA2 deficiency impairs macrophage NO production in acute
T. cruzi infection and that this results in an increased parasite
content in the hearts of infected mice.
DISCUSSION
A characteristic pathological feature in Chagas disease is cardiac
inflammation during both the acute and chronic stages. Acute
parasitemia elicits the transmigration of inflammatory cells across
the endothelial cell barrier to the myocardium, and this process
involves the increased expression of adhesion molecules and pro-
inflammatory cytokines whenT. cruzi infects endothelial cells (19,
20).We and others have demonstrated previously that infection of
endothelial cells withT. cruzi results in significant PAFproduction
and the upregulation of cell surface adhesion molecules that can
directly contribute to inflammatory cell recruitment to infected
sites (4, 19, 20). We have also recently shown that endothelial cell
PAF production following T. cruzi infection requires iPLA2 (4),
which suggested that prolonged endothelial cell activation in
chronic Chagas disease may be associated with iPLA2 activation
and PAF production, which facilitates the recruitment and trans-
migration of inflammatory cells to sites of infection. However, the
absence of iPLA2 did not result in a significant decrease in in-
flammatory cells in the myocardium, despite the significant de-
crease in PAF production in T. cruzi-infected endothelial cells
from the iPLA2-KO mouse heart (Fig. 1). In this study, we ob-
served a significant increase in cell surface expression of adhesion
molecules in response to T. cruzi infection that was not signifi-
cantly affected by the absence of iPLA2. Since we did not observe
a difference in inflammatory cells in the hearts of WT or
iPLA2-KO mice infected with T. cruzi, our data suggest that the
FIG 3 NO release from cells of the murine macrophage cell line RAW 264.7
following infection with T. cruzi (MOI, 0.2) with or without IFN- (100 units)
for 24 h. **, P  0.01 compared to untreated cells; , P  0.05 compared to
treated or infected cells in the presence or absence of BEL (0.5 M);, P
0.01 compared to treated or infected cells in the presence or absence of BEL
(0.5 M). The values shown are means SEMs for 4 separate cell cultures.
Sharma et al.
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upregulation of adhesionmolecules is sufficient to recruit inflam-
matory cells across the endothelium in the presence of decreased
PAF production.
Macrophages comprise key immune cells found in chagasic
lesions and play an important role in parasite clearance via NO
production (21, 22). Previous studies have suggested that iPLA2
may be required for iNOS upregulation in macrophages through
activation of cyclic AMP response element-binding protein
(CREB) via iPLA2-derived lysoplasmenylcholine (23). iPLA2 has
been demonstrated to be important in macrophage chemotaxis
(14), and macrophage iPLA2 has recently been shown to gener-
ate lysophosphatidic acid, which is required for increased NADP
oxidase 4 (Nox4) expression and H2O2 generation (15). These
studies suggest a possible mechanism by which NO production in
iPLA2-deficient macrophages and tissue parasite clearance are
impaired.We demonstrated here that pretreatment of RAW264.7
cells with the iPLA2 inhibitor (S)-BEL [but not with its (R)-BEL
enantiomer] blunted the NO production induced by T. cruzi in-
fection and its amplification by coincubation with IFN-, which
indicates that iPLA2 contributes to NO production. Further
studies were performed using bonemarrow-derivedmacrophages
obtained from T. cruzi-infectedWT and iPLA2-KOmice with or
without IFN-. In agreement with previously published data (21,
22), macrophages from iPLA2-KO mice released less NO than
cells from WT mice. Thus, the absence of iPLA2 results in im-
paired parasite clearing by murine macrophages attributable to
their diminished NO production, and this could explain the in-
creased cardiac parasite load in iPLA2-KOmice infected with T.
cruzi. An increased tissue parasite load could eventually result in
greatermyocardial damage andmore adverse clinical outcomes in
patients with chronic Chagas disease. The knowledge that parasite
clearance bymacrophages requires iPLA2-dependentNO release
may lead to new avenues for therapeutic interventions in Chagas
disease.
In conclusion, these data indicate that iPLA2 plays an impor-
tant role in host defense against trypanosome infection by con-
tributing significantly to macrophage NO production. The signif-
icance of endothelial cell iPLA2-dependent PAF production in
cardiac inflammation during acute Chagas disease remains uncer-
tain, but recruitment of inflammatory cells is enhanced inT. cruzi-
infected endothelial cells. Because inflammation is a carefully reg-
ulated process involving several mediators with some redundancy
in function, impaired PAF production may only minimally affect
the recruitment of inflammatory cells across the endothelium fol-
lowingT. cruzi infection in vivo, and this might be offset in part by
the concomitant increase in cell surface expression of endothelial
adhesion molecules.
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